Merck is a global company based in Darmstadt and with a history of almost 350 years the world’s oldest pharmaceutical and chemical company.
We are Merck, the original, and hold the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where we are known as EMD.
Our products comprise innovative pharmaceuticals and biopharmaceuticals, specialty chemicals, high-tech materials and life science tools. The four business sectors responsible for this product range are Merck Serono, Consumer Health, Performance Materials and Merck Millipore.
Around 40,000 employees work in 66 countries to improve the quality of life for patients and to further the success of our customers. We generated total revenues of € 11.1 billion in 2013 and spent € 1.5 billion on research and development. Merck Serono generated almost € 6 billion worth of income.
Merck Serono is continuously investing in research and development in specialized therapeutic areas such as oncology, immuno-oncology, immunology and neurodegenerative diseases.
The group mainly involved in the project is Drug Delivery and Innovation (belonging to the unit Chemical & Pharmaceutical Development). It contributes a particular experience on pre-clinical formulation and analysis of small molecules, peptides and proteins, as well as on the development and characterization of innovative drug delivery systems. The special expertise of the group includes nanosuspensions for the bioavailability enhancement of poorly soluble compounds, and protein vaccines based on liposomes or silica nanoparticles, as proven by several patent applications and scientific publications.